Skip to main content
logo
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
15.01
-0.18 (-1.18%)
At close: Sep 4, 2026, 4:00 PM EDT
15.04
+0.03 (0.20%)
After-hours: Sep 4, 2026, 7:30 PM EDT

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,2779413,4153,620409-
Market Cap Growth
-66.19%-72.45%-5.66%784.47%--
Enterprise Value
8426382,9323,189353-
Last Close Price
15.0113.1854.1560.3910.509.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.933.097.537.055.95-
P/TBV Ratio
2.983.097.647.308.37-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.250.010.010.00-1.29
Net Debt / Equity Ratio
-1.02-1.04-0.98-0.99-1.04-0.60
Net Debt / EBITDA Ratio
1.641.313.149.441.11-0.20
Net Debt / FCF Ratio
1.931.623.8011.781.29-0.16
Quick Ratio
11.988.7720.0751.389.440.39
Current Ratio
12.569.2721.1151.599.980.46
Return on Equity (ROE)
-67.47%-60.78%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-32.44%-33.92%-17.81%-11.21%-93.99%-
Return on Capital Employed (ROCE)
-50.80%-64.60%-31.40%-10.50%-94.00%300.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.64%-24.16%-3.48%-1.00%-12.21%-
FCF Yield
-17.63%-20.84%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-9.53%-2.54%-27.99%-67.30%-274.47%-
SEC Filings: 10-K · 10-Q